The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Lysosomal storage disease overview
Open accessAbstract
The lysosomal storage diseases (LSDs) are a group of inherited metabolic disorders that are caused for the most part by enzyme deficiencies within the lysosome resulting in accumulation of undegraded substrate. This storage process leads to a broad spectrum of clinical manifestations depending on the specific substrate and site of accumulation. Examples of LSDs include the mucopolysaccharidoses, mucolipidoses, oligosaccharidoses, Pompe disease, Gaucher disease, Fabry disease, the Niemann-Pick disorders, and neuronal ceroid lipofuscinoses. This review summarizes the main clinical features, diagnosis, and management of LSDs with an emphasis on those for which treatment is available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
Mehta, A., Ricci, R., Widmer, U., Dehout, F., Garcia de Lorenzo, A., Kampmann, C., Linhart, A., Sunder‐Plassmann, G., Ries, M., & Beck, M. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01309.x · Cited by 848
Recombinant human acid α-glucosidase: Major clinical benefits in infantile-onset Pompe disease
Kishnani, P. S., Corzo, D., Nicolino, M., Byrne, B., Mandel, H., Hwu, W. L., Leslie, N., Levine, J., Spencer, C., McDonald, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000251268.41188.04 · Cited by 781
Fabry disease revisited: Management and treatment recommendations for adult patients
Ortiz, A., Germain, D. P., Desnick, R. J., Politei, J., Mauer, M., Burlina, A., Eng, C., Hopkin, R. J., Laney, D., Linhart, A., et al. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.02.014 · Cited by 650
Pompe disease diagnosis and management guideline
Kishnani, P. S., Steiner, R. D., Bali, D., Berger, K., Byrne, B. J., Case, L. E., Crowley, J. F., Downs, S., Howell, R. R., Kravitz, R. M., et al. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000218152.87434.f3 · Cited by 632
Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study
Patterson, M. C., Vecchio, D., Prady, H., Abel, L., & Wraith, J. E. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70194-1 · Cited by 608
The Gaucher Registry: Demographics and Disease Characteristics of 1698 Patients With Gaucher Disease
Charrow, J., Andersson, H. C., Kaplan, P., Kolodny, E. H., Mistry, P., Pastores, G., Rosenbloom, B. E., Scott, C. R., Wappner, R. S., Weinreb, N. J., et al. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.18.2835 · Cited by 574
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
Germain, D. P., Hughes, D. A., Nicholls, K., Bichet, D. G., Giugliani, R., Wilcox, W. R., Feliciani, C., Shankar, S. P., Ezgu, F., Amartino, H., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510198 · Cited by 555
Weinreb, N. J., Charrow, J., Andersson, H. C., Kaplan, P., Kolodny, E. H., Mistry, P., Pastores, G., Rosenbloom, B. E., Scott, C. R., Wappner, R. S., et al. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01150-6 · Cited by 546
Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry
Wilcox, W. R., Oliveira, J. P., Hopkin, R. J., Ortiz, A., Banikazemi, M., Feldt-Rasmussen, U., Sims, K., Waldek, S., Pastores, G. M., Lee, P., et al. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.09.013 · Cited by 544
Overview of the mucopolysaccharidoses
Muenzer, J. (2011) · Rheumatology · doi:10.1093/rheumatology/ker394 · Cited by 486
Recommendations for the diagnosis and management of Niemann–Pick disease type C: An update
Patterson, M. C., Hendriksz, C. J., Walterfang, M., Sedel, F., Vanier, M. T., & Wijburg, F. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.03.012 · Cited by 475
BRANTON, M. H., SCHIFFMANN, R., SABNIS, S. G., MURRAY, G. J., QUIRK, J. M., ALTARESCU, G., GOLDFARB, L., BRADY, R. O., BALOW, J. E., AUSTIN, H. A., et al. (2002) · Medicine · doi:10.1097/00005792-200203000-00003 · Cited by 461
Therapeutic goals in the treatment of Gaucher disease
Pastores, G. M., Weinreb, N. J., Aerts, H., Andria, G., Cox, T. M., Giralt, M., Grabowski, G. A., Mistry, P. K., & Tylki-Szymańska, A. (2004) · Seminars in Hematology · doi:10.1053/j.seminhematol.2004.07.009 · Cited by 422
Analysis and Classification of 304 Mutant Alleles in Patients with Type 1 and Type 3 Gaucher Disease
Koprivica, V., Stone, D. L., Park, J. K., Callahan, M., Frisch, A., Cohen, I. J., Tayebi, N., & Sidransky, E. (2000) · The American Journal of Human Genetics · doi:10.1086/302925 · Cited by 334
Types A and B Niemann-Pick disease
Schuchman, E. H., & Desnick, R. J. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.12.008 · Cited by 334
Aldenhoven, M., Wynn, R. F., Orchard, P. J., O’Meara, A., Veys, P., Fischer, A., Valayannopoulos, V., Neven, B., Rovelli, A., Prasad, V. K., et al. (2015) · Blood · doi:10.1182/blood-2014-11-608075 · Cited by 321
Natural history of Fabry disease in females in the Fabry Outcome Survey
Deegan, P. B., Baehner, A. F., Barba Romero, M.-Á., Hughes, D. A., Kampmann, C., & Beck, M. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.036327 · Cited by 304
Schoser, B., Stewart, A., Kanters, S., Hamed, A., Jansen, J., Chan, K., Karamouzian, M., & Toscano, A. (2017) · Journal of Neurology · doi:10.1007/s00415-016-8219-8 · Cited by 259
Scarpa, M., Almássy, Z., Beck, M., Bodamer, O., Bruce, I. A., De Meirleir, L., Guffon, N., Guillén-Navarro, E., Hensman, P., Jones, S., et al. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-72 · Cited by 237
Elstein, D., Hollak, C., Aerts, J. M. F. G., van Weely, S., Maas, M., Cox, T. M., Lachmann, R. H., Hrebicek, M., Platt, F. M., Butters, T. D., et al. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000045756.54006.17 · Cited by 234
Randomized, controlled trial of miglustat in Gaucher's disease type 3
Schiffmann, R., FitzGibbon, E. J., Harris, C., DeVile, C., Davies, E. H., Abel, L., Van Schaik, I. N., Benko, W. S., Timmons, M., Ries, M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21491 · Cited by 233
New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses
Williams, R. E., & Mole, S. E. (2012) · Neurology · doi:10.1212/wnl.0b013e31825f0547 · Cited by 232
Krivit, W. (1995) · Cell Transplantation · doi:10.1016/0963-6897(95)00021-o · Cited by 208
European expert consensus statement on therapeutic goals in Fabry disease
Wanner, C., Arad, M., Baron, R., Burlina, A., Elliott, P. M., Feldt-Rasmussen, U., Fomin, V. V., Germain, D. P., Hughes, D. A., Jovanovic, A., et al. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.06.004 · Cited by 208
Hendriksz, C. J., Burton, B., Fleming, T. R., Harmatz, P., Hughes, D., Jones, S. A., Lin, S., Mengel, E., Scarpa, M., Valayannopoulos, V., et al. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9715-6 · Cited by 207
A Prospective, Cross-sectional Survey Study of the Natural History of Niemann-Pick Disease Type B
McGovern, M. M., Wasserstein, M. P., Giugliani, R., Bembi, B., Vanier, M. T., Mengel, E., Brodie, S. E., Mendelson, D., Skloot, G., Desnick, R. J., et al. (2008) · Pediatrics · doi:10.1542/peds.2007-3016 · Cited by 203
The emerging phenotype of long-term survivors with infantile Pompe disease
Prater, S. N., Banugaria, S. G., DeArmey, S. M., Botha, E. G., Stege, E. M., Case, L. E., Jones, H. N., Phornphutkul, C., Wang, R. Y., Young, S. P., et al. (2012) · Genetics in Medicine · doi:10.1038/gim.2012.44 · Cited by 197
Patterson, M. C., Mengel, E., Wijburg, F. A., Muller, A., Schwierin, B., Drevon, H., Vanier, M. T., & Pineda, M. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-12 · Cited by 195
Mucopolysaccharidosis type IIIA: Clinical spectrum and genotype‐phenotype correlations
Valstar, M. J., Neijs, S., Bruggenwirth, H. T., Olmer, R., Ruijter, G. J. G., Wevers, R. A., van Diggelen, O. P., Poorthuis, B. J., Halley, D. J., & Wijburg, F. A. (2010) · Annals of Neurology · doi:10.1002/ana.22092 · Cited by 194
Pineda, M., Wraith, J. E., Mengel, E., Sedel, F., Hwu, W.-L., Rohrbach, M., Bembi, B., Walterfang, M., Korenke, G. C., & Marquardt, T. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.07.003 · Cited by 192
Consensus treatment recommendations for late‐onset Pompe disease
Cupler, E. J., Berger, K. I., Leshner, R. T., Wolfe, G. I., Han, J. J., Barohn, R. J., Kissel, J. T., & of the AANEM CONSENSUS COMMITTEE ON LATE‐ONSET POMPE DISEASE (2012) · Muscle & Nerve · doi:10.1002/mus.22329 · Cited by 176
McGovern, M. M., Avetisyan, R., Sanson, B.-J., & Lidove, O. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0572-x · Cited by 175
Neuronal ceroid lipofuscinoses
Nita, D. A., Mole, S., & Minassian, B. A. (2016) · Epileptic Disorders · doi:10.1684/epd.2016.0844 · Cited by 172
Long-Term Miglustat Therapy in Children With Niemann-Pick Disease Type C
Patterson, M. C., Vecchio, D., Jacklin, E., Abel, L., Chadha-Boreham, H., Luzy, C., Giorgino, R., & Wraith, J. E. (2010) · Journal of Child Neurology · doi:10.1177/0883073809344222 · Cited by 166
Recommendations for the detection and diagnosis of Niemann-Pick disease type C: An update
Patterson, M. C., Clayton, P., Gissen, P., Anheim, M., Bauer, P., Bonnot, O., Dardis, A., Dionisi-Vici, C., Klünemann, H.-H., Latour, P., et al. (2017) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000399 · Cited by 162
Clinical course of sly syndrome (mucopolysaccharidosis type VII)
Montaño, A. M., Lock-Hock, N., Steiner, R. D., Graham, B. H., Szlago, M., Greenstein, R., Pineda, M., Gonzalez-Meneses, A., Çoker, M., Bartholomew, D., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103322 · Cited by 160
Growth charts for patients affected with Morquio A disease
Montaño, A. M., Tomatsu, S., Brusius‐Facchin, A. C., Smith, M. G., & Orii, T. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32281 · Cited by 155
International guidelines for the management and treatment of Morquio A syndrome
Hendriksz, C. J., Berger, K. I., Giugliani, R., Harmatz, P., Kampmann, C., Mackenzie, W. G., Raiman, J., Solano, M. L., & Savarirayan, R. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36833 · Cited by 153
Pompe disease: Design, methodology, and early findings from the Pompe Registry
Byrne, B. J., Kishnani, P. S., Case, L. E., Merlini, L., Müller‐Felber, W., Prasad, S., & van der Ploeg, A. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.02.004 · Cited by 150
The clinical management of type 2 Gaucher disease
Weiss, K., Gonzalez, A. N., Lopez, G. J., Pedoeim, L., Groden, C. A., & Sidransky, E. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.11.008 · Cited by 148
Bone Marrow Transplantation in Children with Hunter Syndrome: Outcome after 7 to 17 Years
Guffon, N., Bertrand, Y., Forest, I., Fouilhoux, A., & Froissart, R. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.11.041 · Cited by 135
Management Strategies for CLN2 Disease
Williams, R. E., Adams, H., Blohm, M. E. G., Cohen-Pfeffer, J. L., Reyes, E. D. L., Denecke, J., Drago, K., Fairhurst, C., Frazier, M., Guelbert, N. B., et al. (2017) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2017.01.034 · Cited by 124
Revised recommendations for the management of Gaucher disease in children
Kaplan, P. B., Baris, H. N., Meırleır, L. D., Rocco, M. D., El-Beshlawy, A. M., Huemer, M., Martins, A. M., Naşcu, I., Rohrbach, M., Steinbach, L. S., et al. (2012) · European Journal of Pediatrics · doi:10.1007/s00431-012-1771-z · Cited by 123
A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA
Shapiro, E., Nestrašil, I., Delaney, K. A., Rudser, K. R., Kovac, V., Nair, N., Richard, C. W., Haslett, P. A. J., & Whitley, C. B. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.11.079 · Cited by 123
The management and treatment of children with Fabry disease: A United States-based perspective
Hopkin, R. J., Jefferies, J. L., Laney, D. A., Lawson, V. H., Mauer, M. S., Taylor, M. R. G., & Wilcox, W. R. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.10.007 · Cited by 121
Cerliponase Alfa: First Global Approval
Markham, A. (2017) · Drugs · doi:10.1007/s40265-017-0771-8 · Cited by 120
Epidemiology and natural history of Gaucher's disease
Mehta, A. B. (2006) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2006.07.005 · Cited by 117
Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency
McGovern, M. M., Dionisi‐Vici, C., Giugliani, R., Hwu, W., Lidove, O., Lukács, Z., Mengel, K. E., Mistry, P. K., Schuchman, E. H., & Wasserstein, M. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.7 · Cited by 117
Biegstraaten, M., Cox, T., Belmatoug, N., Berger, M., Collin-Histed, T., Dahl, S., Dirocco, M., Fraga, C., Giona, F., Giraldo, P., et al. (2018) · Blood Cells, Molecules & Diseases · doi:10.1016/j.bcmd.2016.10.008 · Cited by 116
A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA
Jones, S. A., Breen, C., Heap, F., Rust, S., de Ruijter, J., Tump, E., Marchal, J. P., Pan, L., Qiu, Y., Chung, J.-K., et al. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.05.006 · Cited by 115
Neurological deterioration in late infantile neuronal ceroid lipofuscinosis
Worgall, S., Kekatpure, M. V., Heier, L., Ballon, D., Dyke, J. P., Shungu, D. C., Mao, X., Kosofsky, B. E., Kaplitt, M. G., Souweidane, M. M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000267885.47092.40 · Cited by 112
Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency
Wasserstein, M., Jones, S. A., Soran, H., Díaz, G. A., Lippa, N. C., Thurberg, B. L., Culm-Merdek, K., Shamiyeh, E., Inguilizian, H., Cox, G. F., et al. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.05.013 · Cited by 111
Wraith, J. E., Guffon, N., Rohrbach, M., Hwu, W., Korenke, G. C., Bembi, B., Luzy, C. P., Giorgino, R., & Sedel, F. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.06.009 · Cited by 107
Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II
Kubaski, F., Yabe, H., Suzuki, Y., Seto, T., Hamazaki, T., Mason, R. W., Xie, L., Onsten, T. G. H., Leistner‐Segal, S., Giugliani, R., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.06.020 · Cited by 106
On behalf of the NPC Registry investigators, Patterson, M. C., Mengel, E., Vanier, M. T., Schwierin, B., Muller, A., Cornelisse, P., & Pineda, M. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0284-z · Cited by 99
Mistry, P. K., Lukina, E., Turkia, H. B., Shankar, S. P., Baris, H. N., Ghosn, M. G., Mehta, A. B., Packman, S., Pastores, G. M., Petakov, M. S., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24877 · Cited by 97
Bertola, F., Filocamo, M., Casati, G., Mort, M. E., Rosano, C., Tylki‐Szymańska, A., Tüysüz, B., Gabrielli, O., Grossi, S., Scarpa, M., et al. (2011) · Human Mutation · doi:10.1002/humu.21479 · Cited by 83
Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel
Tarnopolsky, M. A., Katzberg, H. D., Petrof, B. J., Sirrs, S. M., Sarnat, H. B., Myers, K. A., Dupré, N., Dodig, D., Genge, A. L., Venance, S. L., et al. (2016) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2016.37 · Cited by 80
Fraser, J. R. E., Wraith, J. E., & Delatycki, M. (2002) · Clinical Genetics · doi:10.1034/j.1399-0004.2002.620512.x · Cited by 72
Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment
Shapiro, E., Nestrašil, I., Rudser, K. D., Delaney, K. A., Kovac, V., Ahmed, A., Yund, B. D., Orchard, P. J., Eisengart, J. B., Niklason, G. R., et al. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.06.002 · Cited by 71
El-Beshlawy, A. M., Tylki‐Szymańska, A., Vellodi, A., Belmatoug, N., Grabowski, G. A., Kolodny, E. H., Batista, J. L., Cox, G. F., & Mistry, P. K. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.12.001 · Cited by 69
Quantitative clinical characteristics of 53 patients with MPS VII: a cross-sectional analysis
Zielonka, M., Garbade, S. F., Kölker, S., Hoffmann, G. F., & Ries, M. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.10 · Cited by 61
Anderson, L. J., Wyatt, K. M., Henley, W., Nikolaou, V., Waldek, S., Hughes, D. A., Pastores, G. M., & Logan, S. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9717-4 · Cited by 51
van Capelle, C. I., Poelman, E., Frohn-Mulder, I. M. E., Koopman, L. P., van den Hout, J. M. P., Régal, L., Cools, B., Helbing, W. A., & van der Ploeg, A. T. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.07.091 · Cited by 45
Smith, L. D., Rhead, W. J., Charrow, J., Shankar, S. P., Bavdekar, A., Longo, N., Mardach, R., Harmatz, P., Hangartner, T. N., Lee, H., et al. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.05.012 · Cited by 38
Pérez-Poyato, M. S., Marfa, M. P., Ferrer, I., Rodríguez‐Revenga, L., Sánchez, V. C., González, M. J. M., Puñal, J. M. E., Pérez, A. V., González, M. M. G., Bermejo, A. M., et al. (2012) · Journal of Child Neurology · doi:10.1177/0883073812448459 · Cited by 37
Marshall, N. R., Hassiotis, S., King, B. M., Rozaklis, T., Trim, P. J., Duplock, S. K., Winner, L. K., Beard, H., Snel, M. F., Jolly, R. D., et al. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.09.008 · Cited by 28
Philippart, M., Engel, J., & Zimmermann, E. (1983) · Annals of Neurology · doi:10.1002/ana.410140419 · Cited by 26
Late infantile neuronal ceroid lipofuscinosis
INSERM (2020) · Definitions · doi:10.32388/g86tu2 · Cited by 26
Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease
McDowell, R. F. C., Li, J. S., Benjamin, D. K., Morgan, C. L., Becker, A., Kishnani, P. S., & Kanter, R. J. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e318183722f · Cited by 24
Neuronal Ceroid Lipofuscinoses
Caillaud, C., & Sedel, F. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780199972135.003.0059 · Cited by 10
Consensus recommendation on a diagnostic guideline for acid sphingomyelinase deficiency
Wasserstein, M., Dionisi‐Vici, C., Giugliani, R., Hwu, P. W.-L., Lidove, O., Lukács, Z., Mengel, E., Mistry, P. K., Schuchman, E. H., & McGovern, M. M. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.11.366 · Cited by 3
Cited by
Quinville, B. M., Deschenes, N. M., Ryckman, A. E., & Walia, J. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115793 · Cited by 343
Gene therapy advances: A meta-analysis of AAV usage in clinical settings
Au, H. K. E., Isalan, M., & Mielcarek, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.809118 · Cited by 284
GBA, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches
Riboldi, G. M., & Di Fonzo, A. B. (2019) · Cells · doi:10.3390/cells8040364 · Cited by 274
Pathomechanisms in the neuronal ceroid lipofuscinoses
Nelvagal, H. R., Lange, J., Takahashi, K., Tarczyluk-Wells, M. A., & Cooper, J. D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165570 · Cited by 80
Gowrishankar, S., Lyons, L., Rafiq, N. M., Roczniak-Ferguson, A., De Camilli, P., & Ferguson, S. M. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-06-0382 · Cited by 62
Metadata
- Authors
- Sun, A.
- Venue
- Annals of Translational Medicine
- Publisher
- AME Publishing Company
- Published
- 2018-12
- Volume
- 6
- Issue
- 24
- Pages
- 476.-476.
- ISSN
- 2305-5839 (ISSN-L)
- 2305-5847
- OpenAlex
- W2974061697
- Cited by
- 271
- References
- 72
- FWCI
- 13.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.